National Health Investors Inc: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Aug 6, 2025 and accepted by EDGAR at Aug 6, 2025, 16:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $14.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-01-01 to 2025-06-30 | $28.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Interest expense | 3 months2025-04-01 to 2025-06-30 | $15.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2025-01-01 to 2025-06-30 | $29.3m | us-gaap:InterestExpense |
| Net income | 3 months2025-04-01 to 2025-06-30 | $37.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-01-01 to 2025-06-30 | $71.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | $0.79 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-01-01 to 2025-06-30 | $1.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | $0.79 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-01-01 to 2025-06-30 | $1.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 46,822,465 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-01-01 to 2025-06-30 | 46,350,498 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-01-01 to 2025-06-30 | $106.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2025-01-01 to 2025-06-30 | $83.1m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2025-06-30 | $18.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2025-06-30 | $2.70bn | us-gaap:Assets |
| Total liabilities | At period end2025-06-30 | $1.20bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-06-30 | $1.48bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000877860-25-000135. Last ingested by Listed: Oct 30, 2026, 13:56 ET. Listed shows no prices and gives no investment advice.